BioSpace News Archive

BioCapital

Retrophin Gift to Establish Rare Disease Network at Children’s National

Children’s National Health System and Retrophin are pleased to announce the creation of the Retrophin Rare Disease Network at Children’s National.

January 11, 2018
·
2 min read
Business

Endonovo Therapeutics Engages ShareIntel, A Leader in Shareholder Intelligence Services to Investigate Market Maker and Clearing Firm Irregularities

This will enable Endonovo to proactively track equity flows, identify parties to suspicious, aberrant and/or unusual trading activity and deploy action steps to help curtail such activity.

January 11, 2018
·
3 min read
Pharm Country

Rgenix Announces Publication In Cell Demonstrating Activation of LXR/ApoE with RGX-104 Enhances Antitumor Immunity

Rgenix announced today the publication of clinical and pre-clinical results by research collaborators at Rgenix and The Rockefeller University.

January 11, 2018
·
3 min read
Drug Development

Novan to Present Positive Phase II Results for SB208 Antifungal Program at Winter Clinical Dermatology Conference

The data will be presented at the Winter Clinical Dermatology Conference on January 12th through the 17th.

January 11, 2018
·
7 min read
Business

Novan Announces Closing of Offering of Common Stock and Warrants

The terms of the completed offering are consistent with the terms which were outlined in the Company’s press release on January 5, 2018.

January 11, 2018
·
3 min read
Business

Ferring and the Chinese Academy of Sciences Collaborate to Advance Research in Reproductive Medicine

Ferring and the Chinese Academy of Sciences announced a long-term collaboration to advance basic and translational research in reproductive medicine through the development of novel product candidates and therapeutic strategies.

January 11, 2018
·
4 min read
Business

CannaRoyalty and Aequus Pharma Announce Joint Venture to Develop and Commercialize Cannabis-Based Therapies Targeting Neurological Disorders

CannaRoyalty and Aequus today announced a collaboration to advance a suite of cannabis-based therapies targeting neurological disorders into clinical trials in Canada, in collaboration with Canadian doctors and key opinion leaders.

January 11, 2018
·
7 min read
Business

Forty Seven to Collaborate on a Novel Immuno-Oncology Combination for Leukemia and Bladder Cancer

Forty Seven today announced an agreement with Genentech for Genentech to sponsor two clinical trials.

January 11, 2018
·
2 min read
Gencurix Publishes Companion Diagnostics Technology with Reflection of Quality of Nucleic Acid Samples in International Journal

Gencurix announced that the nucleic acid quality index (iQC index), allowing the measurement of the quality of the nucleic acid in molecular diagnosis is published in the Journal of Scientific Reports on Jan 2.

January 11, 2018
·
6 min read
HedgePath Pharma Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regulatory Approval Programs

This latest investment by Mayne Pharma will support HPPI’s clinical and regulatory efforts during 2018 toward the anticipated filing of the SUBA-Itraconazole BCCNS NDA with FDA during 2018.

January 11, 2018
·
7 min read